Recent advances in uveal melanoma treatment-Reference-Cited by-同舟云学术

Recent advances in uveal melanoma treatment

Published:2017-07-31 Issue:6 Volume:37 Page:1350-1372
ISSN:0198-6325
Container-title:Medicinal Research Reviews
language:en
Short-container-title:Med. Res. Rev.

Author:

Álvarez-Rodríguez Beatriz¹,Latorre Alfonso¹,Posch Christian²³^ORCID,Somoza Álvaro¹^ORCID

Affiliation:

1. Instituto Madrileño de Estudios Avanzados en Nanociencia (IMDEA Nanociencia); CNB-CSIC-IMDEA Nanociencia Associated Unit “Unidad de Nanobiotecnología,”; Madrid Spain

2. Department of Dermatology and Venerology; Rudolfstiftung Hospital; Vienna Austria

3. School of Medicine; Sigmund Freud University; Vienna Austria

Funder

Ministerio de Economía y Competitividad

Fundación Científica Asociación Española Contra el Cáncer

Publisher

Wiley

Subject

Drug Discovery,Pharmacology,Molecular Medicine

Reference101 articles.

1. Uveal melanoma: from diagnosis to treatment and the science in between;Chattopadhyay;Cancer.,2016

2. Uveal melanoma: relatively rare but deadly cancer;Kaliki;Eye.,2017

3. The biology of uveal melanoma;Amaro;Cancer Metastasis Rev,2017

4. Tumor characteristics, genetics, management, and the risk of metastasis in uveal melanoma;Nichols;Semin Ophthalmol,2016

5. The genetics of uveal melanoma: current insights;Hoiom;Appl Clin Genet.,2016

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent approaches for the treatment of uveal melanoma: Opportunities and challenges;Critical Reviews in Oncology/Hematology;2024-01

2. Biological characteristics and clinical management of uveal and conjunctival melanoma;Oncology Research;2024

3. Multi-omics approaches identify novel prognostic biomarkers of autophagy in uveal melanoma;Journal of Cancer Research and Clinical Oncology;2023-09-19

4. PI3K/AKT/mTOR pathway-derived risk score exhibits correlation with immune infiltration in uveal melanoma patients;Frontiers in Oncology;2023-04-20

5. Elaiophylin Inhibits Tumorigenesis of Human Uveal Melanoma by Suppressing Mitophagy and Inducing Oxidative Stress via Modulating SIRT1/FoxO3a Signaling;Frontiers in Oncology;2022-03-21